Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 9 de 9
Chinese Acupuncture & Moxibustion ; (12): 669-678, 2023.
Article in Chinese | WPRIM | ID: wpr-980777


OBJECTIVE@#To observe the effects of electroacupuncture (EA) pretreatment on cardiac function, sympathetic nerve activity, indexes of myocardial injury and GABAA receptor in fastigial nucleus in rats with myocardial ischemia reperfusion injury (MIRI), and to explore the neuroregulatory mechanism of EA pretreatment in improving MIRI.@*METHODS@#A total of 60 male SD rats were randomly divided into a sham operation group, a model group, an EA group, an agonist group and an agonist+EA group, 12 rats in each group. The MIRI model was established by ligation of the left anterior descending coronary artery. EA was applied at bilateral "Shenmen" (HT 7) and "Tongli" (HT 5) in the EA group and the agonist+EA group, with continuous wave, in frequency of 2 Hz and intensity of 1 mA, 30 min each time, once a day for 7 consecutive days. After intervention, the MIRI model was established. In the agonist group, the muscone (agonist of GABAA receptor, 1 g/L) was injected in fastigial nucleus for 7 consecutive days before modeling, 150 μL each time, once a day. In the agonist+EA group, the muscone was injected in fastigial nucleus 30 min before EA intervention. The data of electrocardiogram was collected by PowerLab standard Ⅱ lead, and ST segment displacement and heart rate variability (HRV) were analyzed; the serum levels of norepinephrine (NE), creatine kinase isoenzyme MB (CK-MB) and cardiac troponin I (cTnI) were detected by ELISA; the myocardial infarction area was measured by TTC staining; the morphology of myocardial tissue was observed by HE staining; the positive expression and mRNA expression of GABAA receptor in fastigial nucleus were detected by immunohistochemistry and real-time PCR.@*RESULTS@#Compared with the sham operation group, in the model group, ST segment displacement and ratio of low frequency to high frequency (LF/HF) of HRV were increased (P<0.01), HRV frequency domain analysis showed enhanced sympathetic nerve excitability, the serum levels of NE, CK-MB and cTnI were increased (P<0.01), the percentage of myocardial infarction area was increased (P<0.01), myocardial fiber was broken and interstitial edema was serious, the positive expression and mRNA expression of GABAA receptor in fastigial nucleus were increased (P<0.01). Compared with the model group, in the EA group, ST segment displacement and LF/HF ratio were decreased (P<0.01), HRV frequency domain analysis showed reduced sympathetic nerve excitability, the serum levels of NE, CK-MB and cTnI were decreased (P<0.01), the percentage of myocardial infarction area was decreased (P<0.01), myocardial fiber breakage and interstitial edema were lightened, the positive expression and mRNA expression of GABAA receptor in fastigial nucleus were decreased (P<0.01). Compared with the EA group, in the agonist group and the agonist+EA group, ST segment displacement and LF/HF ratio were increased (P<0.01), HRV frequency domain analysis showed enhanced sympathetic nerve excitability, the serum levels of NE, CK-MB and cTnI were increased (P<0.01), the percentage of myocardial infarction area was increased (P<0.01), myocardial fiber breakage and interstitial edema were aggravated, the positive expression and mRNA expression of GABAA receptor in fastigial nucleus were increased (P<0.01).@*CONCLUSION@#EA pretreatment can improve the myocardial injury in MIRI rats, and its mechanism may be related to the inhibition of GABAA receptor expression in fastigial nucleus, thereby down-regulating the excitability of sympathetic nerve.

Male , Animals , Rats , Rats, Sprague-Dawley , Cerebellar Nuclei , Electroacupuncture , Myocardial Reperfusion Injury/therapy , Receptors, GABA-A/genetics , RNA, Messenger
Ann. hepatol ; 16(2): 297-303, Mar.-Apr. 2017. tab, graf
Article in English | LILACS | ID: biblio-887236


ABSTRACT Introduction and aim. The inability to distinguish cancer (CSCs) from normal stem cells (NSCs) has hindered attempts to identify safer, more effective therapies for hepatocellular carcinoma (HCC). The aim of this study was to document and compare cell membrane potential differences (PDs) of CSCs and NSCs derived from human HCC and healthy livers respectively and determine whether altered GABAergic innervation could explain the differences. Material and methods. Epithelial cell adhesion molecule (EpCAM) positive stem cells were isolated from human liver tissues by magnetic bead separations. Cellular PDs were recorded by microelectrode impalement of freshly isolated cells. GABAA receptor subunit expression was documented by reverse transcriptase polymerase chain reaction (RT-PCR) and immunofluorescence. Results. CSCs were significantly depolarized (-7.0 ± 1.3 mV) relative to NSCs (-23.0 ± 1.4 mV, p < 0.01). The depolarized state was associated with different GABAA receptor subunit expression profiles wherein phasic transmission, represented by GAGAA α3 subunit expression, was prevalent in CSCs while tonic transmission, represented by GABAA α6 subunit expression, prevailed in NSCs. In addition, GABAA subunits α3, β3, γ3 and δ were strongly expressed in CSCs while GABAA π expression was dominant in NSCs. CSCs and NSCs responded similarly to GABAA receptor agonists (ΔPD: 12.5 ± 1.2 mV and 11.0 ± 3.5 mV respectively). Conclusion. The results of this study indicate that CSCs are significantly depolarized relative to NSCs and these differences are associated with differences in GABAA receptor subunit expression. Together they provide new insights into the pathogenesis and possible treatment of human HCC.

Humans , Neoplastic Stem Cells/metabolism , Receptors, GABA-A/metabolism , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/metabolism , GABA-A Receptor Agonists/pharmacology , Epithelial Cell Adhesion Molecule/metabolism , Liver/cytology , Liver Neoplasms/metabolism , Phenotype , Stem Cells/drug effects , Neoplastic Stem Cells/drug effects , RNA, Messenger/genetics , RNA, Messenger/metabolism , Biomarkers/metabolism , Fluorescent Antibody Technique , Immunomagnetic Separation , Receptors, GABA-A/drug effects , Receptors, GABA-A/genetics , Reverse Transcriptase Polymerase Chain Reaction , Protein Subunits , Liver Neoplasms/genetics , Membrane Potentials/drug effects
Braz. dent. j ; 26(2): 105-109, Mar-Apr/2015. tab, graf
Article in English | LILACS | ID: lil-741217


Dried, fresh and glycolic extracts of Zingiber officinale were obtained to evaluate the action against G. mellonella survival assay against Enterococcus faecalis infection. Eighty larvae were divided into: 1) E. faecalis suspension (control); 2) E. faecalis + fresh extract of Z. officinale (FEO); 3) E. faecalis + dried extract of Z. officinale (DEO); 4) E. faecalis + glycolic extract of Z. officinale (GEO); 5) Phosphate buffered saline (PBS). For control group, a 5 μL inoculum of standardized suspension (107 cells/mL) of E. faecalis (ATCC 29212) was injected into the last left proleg of each larva. For the treatment groups, after E. faecalis inoculation, the extracts were also injected, but into the last right proleg. The larvae were stored at 37 °C and the number of dead larvae was recorded daily for 168 h (7 days) to analyze the survival curve. The larvae were considered dead when they did not show any movement after touching. E. faecalis infection led to the death of 85% of the larvae after 168 h. Notwithstanding, in treatment groups with association of extracts, there was an increase in the survival rates of 50% (GEO), 61% (FEO) and 66% (DEO) of the larvae. In all treatment groups, the larvae exhibited a survival increase with statistically significant difference in relation to control group (p=0.0029). There were no statistically significant differences among treatment groups with different extracts (p=0.3859). It may be concluded that the tested extracts showed antimicrobial activity against E. faecalis infection by increasing the survival of Galleria mellonella larvae.

Extratos seco, fresco e glicólico de Zingiber officinale foram obtidos para avaliar suas ações por meio de ensaio de sobrevivência em G. mellonella contra infecção por Enterococcus faecalis. Oitenta larvas foram divididas em: 1) Suspensão de E. faecalis (controle); 2) E. faecalis + extrato fresco de Z. officinale (FEO); 3) E. faecalis + extrato seco de Z. officinale (DEO); 4) E. faecalis + extrato glicólico de Z. officinale (GEO); 5) Solução tampão fosfato salina (PBS). Para o grupo de controle, 5 µL de inóculo de suspensão padronizada (107 células/mL) de E. faecalis (ATCC 29212) foi injetado na última proleg esquerda de cada lagarta. Para os grupos com tratamento, após a injeção de E. faecalis, os extratos foram injetados na última proleg direita. Após as injeções, as lagartas foram armazenadas a 37 °C e o número de animais mortos foi registrado diariamente em 168 h (7 dias) para analisar a curva de sobrevivência. As lagartas foram consideradas mortas quando elas não mostraram qualquer movimento após o toque. A infecção por E. faecalis levou à morte de 85% das lagartas após 168 h. Não obstante, nos grupos de tratamento com associação dos extratos, houve um aumento nas taxas de sobrevivência de 50% (GEO), 61% (FEO) e 66% (DEO) das lagartas. Em todos os grupos com tratamento, as lagartas apresentaram um aumento na sobrevivência, com diferença estatisticamente significativa em relação ao grupo controle (p=0,0029). Não houve diferença estatisticamente significativa entre os tratamentos com os diferentes extratos (p=0,3859). Pode concluir-se que os extratos testados mostraram atividade antimicrobiana contra a infecção por E. faecalis, aumentando a sobrevivência das lagartas de G. mellonella.

Humans , Receptors, GABA-A/chemistry , Binding Sites , Benzamidines/chemistry , Benzamidines/metabolism , Benzamidines/pharmacology , Conserved Sequence , Crystallography, X-Ray , Cell Membrane/chemistry , Cell Membrane/metabolism , Drug Design , GABA-A Receptor Agonists/chemistry , GABA-A Receptor Agonists/metabolism , GABA-A Receptor Agonists/pharmacology , Genetic Predisposition to Disease , Glycosylation , Models, Molecular , Mutation/genetics , Protein Structure, Quaternary , Protein Structure, Tertiary , Protein Subunits , Polysaccharides/chemistry , Polysaccharides/metabolism , Receptors, GABA-A/genetics , Synaptic Transmission
Journal of Forensic Medicine ; (6): 195-197, 2012.
Article in Chinese | WPRIM | ID: wpr-983736


OBJECTIVE@#To investigate the polymorphisms of rs4906902 and rs8179184 loci in the promoter of the gamma-aminobutyric acid(GABA) receptor A, beta3 subunit gene (GABRB3), and their relevance with schizophrenia.@*METHODS@#PCR and DNA sequencing were used to detect the polymorphisms of rs4906902 and rs8179184 loci in 210 healthy individuals (control group) and 206 schizophrenic patients (case group) of the Han population in northern China. The chi2 test was used to identify Hardy-Weinberg equilibrium of the genotype distribution in the control group followed by comparing differences in genotype and haplotype frequency distributions between two groups.@*RESULTS@#Distributions of the genotype frequencies fit the law of Hardy-Weinberg equilibrium in the control group. rs4906902 and rs8179184 loci were in linkage disequilibrium and showed two haplotypes which were T-G and C-A. The differences of genotypic frequencies and haplotype frequencies were statistically significant between the two groups (P < 0.05). The frequency of haplotype C-A in the case group was significantly higher than in the control group. Genotypic and haplotype frequencies in the maternal line and paternal line were statistically significant in the case group (P < 0.05).@*CONCLUSION@#The haplotype of C-A in rs4906902 and rs8179184 loci in the promoter of GABRB3 gene may be maternally inherited and positively associated with schizophrenia and may be a useful tool in the forensic identification of schizophrenia.

Female , Humans , Male , Alleles , Asian People/genetics , China/epidemiology , Gene Frequency , Genetic Predisposition to Disease , Genotype , Haplotypes , Inheritance Patterns , Linkage Disequilibrium , Polymerase Chain Reaction , Polymorphism, Single Nucleotide , Promoter Regions, Genetic , Receptors, GABA-A/genetics , Schizophrenia/genetics , Sequence Analysis, DNA
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; 31(4): 328-331, Dec. 2009. tab
Article in English | LILACS | ID: lil-536744


OBJECTIVE: The γ-aminobutyric acid type A (GABA A) system may be implicated in obsessive-compulsive disorder, based on its major role in modulation of anxiety and its function as the principal inhibitory neurotransmitter system in the cortex. In addition, glutamatergic/GABAergic mechanisms appear to play a role in the pathophysiology of obsessive-compulsive disorder, making the GABA A receptor-γ2 (GABργ2) gene a good candidate for susceptibility in this disorder. METHOD: 118 probands meeting DSM-IV criteria for primary obsessive-compulsive disorder and their available parents were recruited for participation in this study and informed consent was obtained. An NciI restriction site polymorphism in the second intron was genotyped and data was analyzed using the Transmission Disequilibrium Test. RESULTS: In total, 61 of the participating families were informative (i.e., with at least one heterozygous parent). No biases were observed in the transmission of either of the two alleles (χ2 = 0.016, 1 d.f., p = 0.898) to the affected probands in the total sample. CONCLUSION/DISCUSSION: While these results do not provide support for a major role for the GABA A receptor-γ2 in obsessive-compulsive disorder, further investigations of this gene in larger samples are warranted.

OBJETIVO: O sistema gabaérgico tipo A (GABA A) pode estar implicado no transtorno obsessivo-compulsivo devido ao seu grande papel na modulação da ansiedade e da sua função como o principal neurotransmissor inibidor no córtex. Além disso, mecanismos glutamatérgicos/gabaérgicos parecem desempenhar um papel na fisiopatologia do transtorno obsessivo-compulsivo, tornando o gene do receptor GABA A-γ2 (GABRG2) um bom gene candidato para a suscetibilidade genética a este transtorno. MÉTODO: 118 probandos que preencheram os critérios do DSM-IV para transtorno obsessivo-compulsivo primário e seus pais (quando disponíveis) foram recrutados para a participação neste estudo; consentimento informado foi obtido. Um polimorfismo no sítio de restrição da enzima NciI, localizado no íntron 2, foi genotipado e os dados foram analisados utilizando-se o Teste de Desequilíbrio de Transmissão. RESULTADOS: No total, 61 das famílias participantes foram informativas (ou seja, com pelo menos um progenitor heterozigoto). Não foi observado desequilíbrio de transmissão de qualquer um dos dois alelos (χ2 = 0,016, 1 g.l., p = 0,898) aos probandos afetados. CONCLUSÃO/DISCUSSÃO: Apesar de estes resultados não fornecerem suporte para um papel importante para o gene GABA A-γ2 no transtorno obsessivo-compulsivo, novas investigações desse gene em amostras maiores são justificadas.

Adult , Female , Humans , Male , Obsessive-Compulsive Disorder/genetics , Receptors, GABA-A/genetics , Diagnostic and Statistical Manual of Mental Disorders , Gene Frequency , Genetic Predisposition to Disease , Genotype , Linkage Disequilibrium , Polymorphism, Genetic
Yonsei Medical Journal ; : 304-306, 2009.
Article in English | WPRIM | ID: wpr-109386


This study aimed to identify the association between gamma-aminobutyric acid-A (GABA-A) receptor subunit beta3 (GABRB3) gene and autism spectrum disorders (ASD) in Korea. Fifty-eight children with ASD [47 boys (81.0%), 5.5 +/- 4.1 years old], 46 family trios, and 86 healthy control subjects [71 males (82.6%), 33.6 +/- 9.3 years old] were recruited. Transmission disequilibrium test revealed that, 183 bp long allele in GABRB3 gene was preferentially transmitted in families with ASD (p = 0.025), whereas a population-based case-control study, however, showed no association between ASD and GABRB3 microsatellite polymorphism. Our data provide preliminary evidence that GABRB3 gene is associated with ASD in Korea.

Adult , Child , Child, Preschool , Female , Humans , Infant , Male , Asian People/genetics , Autistic Disorder/genetics , Genetic Predisposition to Disease , Korea , Microsatellite Repeats/genetics , Pedigree , Receptors, GABA-A/genetics
Rev. argent. anestesiol ; 66(5): 438-442, oct.-dic. 2008. ilus
Article in Spanish | LILACS | ID: lil-541229


Se presenta un paciente de 13 años de edad con síndrome de Angelman que debe ser sometido a cirugía (colocación de clavo endomedular) por presentar una fractura de húmero derecho. Dada la baja incidencia de este padecimiento, 1 en 4 millones de nacidos vivos4, y a las implicancias anestesiológicas del mismo, nos pareció interesante compartir nuestro caso. Clínicamente se caracteriza por presentar retraso mental severo con ataques de risa compulsiva, ausencia de habla, ataxia cerebelosa, distonía del sistema esquelético, defectos morfológicos de los huesos faciales, convulsiones, alteración del ritmo sueño-vigilia. El síndrome de Angelman está asociado a alteraciones genéticas en el cromosoma 15. Justamente en este cromosoma están codificados genes que participan en la expresión de subunidades del receptor GABA-A, lo cual además de justificar algunas manifestaciones del síndrome, constituye un hecho anestesiológico interesante, ya que sobre dicho receptor actúan muchos de los anestésicos que utilizamos a diario. Se realizó anestesia general balanceada con inducción inhalatoria y un bloqueo del plexo braquial. Se discuten algunas características del síndrome y sus implicancias anestesiológicas.

We present a 13 year-old patient with Angelman syndrome who was admitted for surgery (reduction and internal fixation of right humerus fracture with intramedulary naif). We decided to share our case because of the low incidence of this disease, 1 in 4 million live births and the anesthesiologic implications. The clinical manifestations of this syndrome are severe mental retard with compulsory laughter, lack of speech, cerebellar ataxia, dystonia of the skeletal system, morphological defect of the facial bones, seizures and sleep disturbance. The Angelman syndrome is associated with genetic alterations in the 15 chromosome. The genes responsible of the expression of GABA-A receptor subunits, are codified in this chromosome, therefore this genetic alteration is related not only to the manifestations of this syndrome but has also interesting anesthetic implications, if we consider that many of the anesthetics agents used in our daily practice are thought to activate GABA-A receptors. We performed a balanced general anaesthesia with inhaled induction and a brachial plexus block. We discuss the characteristics of this syndrome and the anesthesiologic implications.

Paciente de 13 anos de idade com síndrome de Angelman precisa ser submetido a cirurgia (colocação de prego endomedular) por apresentar fratura do úmero direito. Por causa da baixa incidencia deste padecimento (um por cada quatro milhóes de nascidos vivos) e suas implicações anestesiológicas, consideramos de interesse compartilhar o nosso caso. O paciente caracteriza-se clinicamente por apresentar retardamento mental acentuado com ataques de riso compulsivo, ausencia de fala, ataxia cerebelar, distonia do sistema esquelético, defeitos morfológicos nos ossos faciais, convulsóes e alteração do ciclo sono-vigilia. A síndrome de Angelman associa-se a variações genéticas no cromossomo 15. Precisamente neste cromossomo estao codificados os genes que participam na expressão de subunidades do receptor GABA-A, que além de explicar algumas manifestaçóes da síndrome, constitui um fato anestesiológico interessante, já que muitos anestésicos utilizados habitualmente atuam sobre esse receptor. Foi feita anestesia geral balanceada com indução inalatória e bloqueio do plexo braquial. Sao analisadas algumas características da síndrome e suas implicações anestesiológicas.

Humans , Male , Adolescent , Anesthesia, General/methods , Monitoring, Intraoperative , Angelman Syndrome/surgery , Anesthesia, Inhalation , Anesthetics, General/administration & dosage , Bone Nails , /genetics , Humeral Fractures/surgery , Postoperative Care , Preanesthetic Medication , Receptors, GABA-A/genetics
Journal of Korean Medical Science ; : 533-538, 2006.
Article in English | WPRIM | ID: wpr-47121


Family, twin, and adoption studies have demonstrated that genes play an important role in the development of alcoholism. We investigated the association between alcoholism and the genetic polymorphisms of the GABA(A) receptor genes on chromosome 5q33-34 in Korean population. The genotype of the GABA(A) receptor gene polymorphisms were determined by performing polymerase chain reaction genotyping for 172 normal controls and 162 male alcoholics who are hospitalized in alcoholism treatment institute. We found a significant association between the genetic polymorphisms of the GABA(A) alpha1 and GABA(A) alpha6 receptor gene and alcoholism. The GG genotype of the GABA(A) alpha1 receptor gene was associated with the onset age of alcoholism and alcohol withdrawal symptoms, and a high score on the Korean version of the ADS. However, there was no association between the genetic polymorphisms of the GABA(A) beta2 and gamma2 receptor gene and alcoholisms. Our finding suggest that genetic polymorphisms of the GABA(A) alpha1 and GABA(A) alpha6 receptor gene may be associated with the development of alcoholism and that the GG genotype of the GABA(A) alpha1 receptor gene play an important role in the development of the early onset and the severe type of alcoholism.

Middle Aged , Male , Humans , Adult , Sequence Analysis, DNA , Receptors, GABA-A/genetics , Polymorphism, Genetic , Models, Statistical , Korea , Genetic Predisposition to Disease , DNA/metabolism , Chromosomes, Human, Pair 5 , Alcoholism/genetics , Age of Onset
J Genet ; 2003 Apr-Aug; 82(1-2): 17-21
Article in English | IMSEAR | ID: sea-114389


An Ala322Asp mutation in the GABRA1 gene was recently reported to be responsible for causing the autosomal dominant (AD) form of juvenile myoclonic epilepsy (JME) in a French-Canadian family. To study if JME families from India exhibiting the AD mode of inheritance carry the Ala322Asp mutation, we examined 35 unrelated JME-affected individuals from such families for the Ala322Asp mutation in GABRA1. Ala322Asp mutation was not observed in any of these JME-affected individuals, suggesting that this mutation is unlikely to be a predominant mutation involved in causation of epilepsy. To evaluate the possibility of other mutation(s) in and around GABRA1 that may predispose to JME, we compared the allele frequencies at two marker loci, D5S2118 and D5S422, flanking GABRA1, in probands and 100 matched population controls. One of the allele frequencies at D5S422 shows a significant difference between the cases and controls (chi-square = 11.44, d.f. = 1, P = 0.0007), suggesting genetic association between JME and genes located in the proximity of the DNA marker.

Adolescent , Amino Acid Substitution , Epilepsy, Generalized/etiology , Family , Female , Gene Frequency , Genetic Predisposition to Disease , Genotype , Humans , India , Genetic Linkage , Male , Microsatellite Repeats , Mutation/genetics , Myoclonic Epilepsy, Juvenile/etiology , Receptors, GABA-A/genetics